Home
MBX
MBX News

Latest MBX BIOSCIENCES INC (MBX) News on June 2, 2025

MBX Biosciences to Participate in June Investor Conferences

GlobeNewswire

13 days ago

MBX Biosciences to Participate in June Investor Conferences

MBX Biosciences Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

GlobeNewswire

21 days ago

MBX Biosciences Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

Companies Like MBX Biosciences (NASDAQ:MBX) Are In A Position To Invest In Growth

Simply Wall St.

a month ago

Companies Like MBX Biosciences (NASDAQ:MBX) Are In A Position To Invest In Growth

MBX Biosciences to Participate in Citizens and RBC May Investor Conferences

GlobeNewswire

a month ago

MBX Biosciences to Participate in Citizens and RBC May Investor Conferences

MBX Biosciences Appoints Veteran Pharmaceutical Executive Steve Hoerter to Board of Directors

GlobeNewswire

2 months ago

MBX Biosciences Appoints Veteran Pharmaceutical Executive Steve Hoerter to Board of Directors

MBX Biosciences to Participate in the 24th Annual Needham Virtual Healthcare Conference

GlobeNewswire

2 months ago

MBX Biosciences to Participate in the 24th Annual Needham Virtual Healthcare Conference

MBX Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights

GlobeNewswire

3 months ago

MBX Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights

Insider Buyers At MBX Biosciences Likely Disappointed With 17% Slide

Simply Wall St.

3 months ago

Insider Buyers At MBX Biosciences Likely Disappointed With 17% Slide

MT Newswires

3 months ago

Top Premarket Decliners

MBX Biosciences Announces Additions to Leadership Team

GlobeNewswire

3 months ago

MBX Biosciences Announces Additions to Leadership Team

MBX Biosciences Completes Enrollment in Phase 2 Avail™ Trial of MBX 2109 (Canvuparatide) for Hypoparathyroidism

GlobeNewswire

3 months ago

MBX Biosciences Completes Enrollment in Phase 2 Avail™ Trial of MBX 2109 (Canvuparatide) for Hypoparathyroidism

MBX Biosciences to Participate in March Investor Conferences

GlobeNewswire

3 months ago

MBX Biosciences to Participate in March Investor Conferences

MBX Biosciences to Participate in Upcoming February Investor Conferences

GlobeNewswire

4 months ago

MBX Biosciences to Participate in Upcoming February Investor Conferences

MBX Biosciences' Investigational Drug For Weight Loss Surgery-Related Low Blood Sugar Shows Encouraging Action

Benzinga

5 months ago

MBX Biosciences' Investigational Drug For Weight Loss Surgery-Related Low Blood Sugar Shows Encouraging Action

MBX Biosciences Announces Positive Phase 1 Topline Results for MBX 1416 for the Treatment of Post-bariatric Hypoglycemia

GlobeNewswire

5 months ago

MBX Biosciences Announces Positive Phase 1 Topline Results for MBX 1416 for the Treatment of Post-bariatric Hypoglycemia

MBX Biosciences to Participate in 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

5 months ago

MBX Biosciences to Participate in 43rd Annual J.P. Morgan Healthcare Conference

MBX Biosciences Announces MBX 2109 Phase 1 Study Results Published in The Journal of Clinical Endocrinology and Metabolism

GlobeNewswire

6 months ago

MBX Biosciences Announces MBX 2109 Phase 1 Study Results Published in The Journal of Clinical Endocrinology and Metabolism

MBX Biosciences Announces Last Subject Last Visit in Phase 1 Trial of MBX 1416 for the Treatment of Post-Bariatric Hypoglycemia

GlobeNewswire

6 months ago

MBX Biosciences Announces Last Subject Last Visit in Phase 1 Trial of MBX 1416 for the Treatment of Post-Bariatric Hypoglycemia

MBX Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire

7 months ago

MBX Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Update

MBX Biosciences to Participate in Upcoming November Investor Conferences

GlobeNewswire

7 months ago

MBX Biosciences to Participate in Upcoming November Investor Conferences

Opening Day: Another trio of biotech IPOs make Friday debut

TipRanks

8 months ago

Opening Day: Another trio of biotech IPOs make Friday debut

MBX Biosciences Presents MBX 2109 Phase 2 Avail™ Hypoparathyroidism Trial Rationale and Design at the ASBMR 2024 Annual Meeting

GlobeNewswire

8 months ago

MBX Biosciences Presents MBX 2109 Phase 2 Avail™ Hypoparathyroidism Trial Rationale and Design at the ASBMR 2024 Annual Meeting

GuruFocus.com

8 months ago

Deep Track Capital, LP's Strategic Acquisition in MBX Biosciences Inc

GuruFocus.com

8 months ago

OrbiMed Advisors LLC Acquires New Stake in MBX Biosciences Inc

MBX Biosciences Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

GlobeNewswire

9 months ago

MBX Biosciences Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Share on Social Networks: